|
gptkbp:instance_of
|
gptkb:fungus
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:amphotericin_B
|
|
gptkbp:caused_by
|
coccidioidomycosis
|
|
gptkbp:first_described_by
|
1892
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Coccidioides immitis
|
|
gptkbp:is_associated_with
|
valley fever
|
|
gptkbp:is_considered_as
|
public health concern
emerging pathogen
|
|
gptkbp:is_found_in
|
gptkb:garden
|
|
gptkbp:is_linked_to
|
chronic lung disease
disseminated disease
|
|
gptkbp:is_monitored_by
|
public health
|
|
gptkbp:is_part_of
|
fungal infections
Coccidioides genus
dimorphic fungi
|
|
gptkbp:is_recognized_by
|
microscopic examination
PCR testing
|
|
gptkbp:is_related_to
|
Coccidioides posadasii
|
|
gptkbp:is_studied_in
|
mycology
infectious diseases
vaccine development
host immune response
pathogenesis
|
|
gptkbp:is_used_in
|
biological research
clinical studies
|
|
gptkbp:is_vulnerable_to
|
bacterial antibiotics
|
|
gptkbp:language
|
laboratories
|
|
gptkbp:lifespan
|
gptkb:Surah
arthroconidia
|
|
gptkbp:native_to
|
gptkb:Mexico
gptkb:Southwestern_United_States
Central and South America
|
|
gptkbp:propagation_method
|
inhalation of spores
|
|
gptkbp:reports_to
|
gptkb:legislation
gptkb:California
gptkb:New_Mexico
gptkb:Arizona
gptkb:Nevada
|
|
gptkbp:risk_factor
|
pregnant women
immunocompromised individuals
people with diabetes
|
|
gptkbp:sensor
|
gptkb:itraconazole
gptkb:amphotericin_B
gptkb:fluconazole
|
|
gptkbp:social_responsibility
|
gptkb:organization
serological tests
|
|
gptkbp:symptoms
|
fatigue
cough
fever
chest pain
joint pain
|
|
gptkbp:treatment
|
gptkb:drug
|
|
gptkbp:was_affecting
|
gptkb:skincare_product
central nervous system
lungs
bones
|